首页> 外文期刊>生物医学研究杂志(英文版) >Impact of crosslinking/riboflavin-UVA-photodynamic inactivation on viability, apoptosis and activation of human keratocytes in vitro
【24h】

Impact of crosslinking/riboflavin-UVA-photodynamic inactivation on viability, apoptosis and activation of human keratocytes in vitro

机译:交联/核黄素-UVA-光动力失活对体外人角膜细胞活力,凋亡和活化的影响

获取原文
获取原文并翻译 | 示例
           

摘要

Riboflavin-UVA photodynamic inactivation is a potential treatment alternative in therapy resistant infectious keratitis.The purpose of our study was to determine the impact of riboflavin-UVA photodynamic inactivation on viability, apop?tosis and activation of human keratocytes in vitro. Primary human keratocytes were isolated from human corneal buttons and cultured in DMEM/Ham's F12 medium supplemented with 10% fetal calf serum. Keratocytes underwent UVA light illumination(375 nm) for 4.10 minutes(2 J/cm2) during exposure to different concentrations of riboflavin. Twenty-four hours after treatment, cell viability was evaluated photometrically, whereas apoptosis, CD34 and alpha-smooth muscle actin(a-SMA) expression were assessed using flow cytometry. We did not detect significant changes in cell viability,apoptosis, CD34 and a-SMA expression in groups only treated with riboflavin or UVA light. In the group treated with riboflavin-UVA-photodynamic inactivation, viability of keratocytes decreased significantly at 0.1% riboflavin(尸<0.01)while the percentage of CD34(尸<0.01 for both 0.05% and 0.1% riboflavin) and alpha-SMA positive keratocytes(P<0.01 and 尸<0.05 for 0.05% and 0.1% riboflavin, respectively) increased significantly compared to the controls.There was no significant change in the percentage of apoptotic keratocytes compared to controls at any of the used ribo?flavin concentrations(P=0.09 and 尸=0.13). We concluded that riboflavin-UVA-photodynamic-inactivation decreases viability of myofibroblastic transformation and multipotent haematopoietic stem cell transformation; however, it does not have an impact on apoptosis of human keratocytes in vitro.

著录项

  • 来源
    《生物医学研究杂志(英文版)》 |2015年第4期|321-325|共5页
  • 作者单位

    Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar 66424, Germany;

    Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar 66424, Germany;

    Department of Ophthalmology, Renmin Hospital of Wuhan University, Wuhan, Hubei 43060, China;

    Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar 66424, Germany;

    Department of Ophthalmology, The Second Hospital of Jilin University, Changchun, Jilin 130041, China;

    Experimental Ophthalmology, Saarland University, Homburg, Saar 66424, Germany;

    Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar 66424, Germany;

    Department of Ophthalmology, Saarland University Medical Center, Homburg, Saar 66424, Germany;

  • 收录信息 中国科学引文数据库(CSCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 角膜疾病;
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号